Evolving epidemiology of reported cryptosporidiosis cases in the United States, 1995-2012
- PMID: 27125575
- PMCID: PMC9150710
- DOI: 10.1017/S0950268815003131
Evolving epidemiology of reported cryptosporidiosis cases in the United States, 1995-2012
Abstract
Cryptosporidium is the leading aetiology of waterborne disease outbreaks in the United States. This report briefly describes the temporal and geographical distribution of US cryptosporidiosis cases and presents analyses of cryptosporidiosis case data reported in the United States for 1995-2012. The Cochran-Armitage test was used to assess changes in the proportions of cases by case status (confirmed vs. non-confirmed), sex, race, and ethnicity over the study period. Negative binomial regression models were used to estimate rate ratios (RR) and 95% confidence intervals (CI) for comparing rates across three time periods (1995-2004, 2005-2008, 2009-2012). The proportion of confirmed cases significantly decreased (P < 0·0001), and a crossover from male to female predominance in case-patients occurred (P < 0·0001). Overall, compared to 1995-2004, rates were higher in 2005-2008 (RR 2·92, 95% CI 2·08-4·09) and 2009-2012 (RR 2·66, 95% CI 1·90-3·73). However, rate changes from 2005-2008 to 2009-2012 varied by age group (P interaction < 0·0001): 0-14 years (RR 0·55, 95% CI 0·42-0·71), 15-44 years (RR 0·99, 95% CI 0·82-1·19), 45-64 years (RR 1·47, 95% CI 1·21-1·79) and ⩾65 years (RR 2·18, 95% CI 1·46-3·25). The evolving epidemiology of cryptosporidiosis necessitates further identification of risk factors in population subgroups. Adding systematic molecular typing of Cryptosporidium specimens to US national cryptosporidiosis surveillance would help further identify risk factors and markedly expand understanding of cryptosporidiosis epidemiology in the United States.
Keywords: Cryptosporidium; water-borne infections.
Figures




Similar articles
-
Cryptosporidiosis surveillance -- United States, 2011-2012.MMWR Suppl. 2015 May 1;64(3):1-14. MMWR Suppl. 2015. PMID: 25928581
-
Cryptosporidiosis surveillance--United States, 2009-2010.MMWR Surveill Summ. 2012 Sep 7;61(5):1-12. MMWR Surveill Summ. 2012. PMID: 22951493
-
Case-case analyses of cryptosporidiosis and giardiasis using routine national surveillance data in the United States - 2005-2015.Epidemiol Infect. 2019 Jan;147:e178. doi: 10.1017/S0950268819000645. Epidemiol Infect. 2019. PMID: 31063098 Free PMC article.
-
A retrospective epidemiological analysis of human Cryptosporidium infection in China during the past three decades (1987-2018).PLoS Negl Trop Dis. 2020 Mar 30;14(3):e0008146. doi: 10.1371/journal.pntd.0008146. eCollection 2020 Mar. PLoS Negl Trop Dis. 2020. PMID: 32226011 Free PMC article.
-
Cryptosporidium and cryptosporidiosis: the African perspective.Environ Sci Pollut Res Int. 2016 Jul;23(14):13811-21. doi: 10.1007/s11356-016-6746-6. Epub 2016 Apr 29. Environ Sci Pollut Res Int. 2016. PMID: 27126869 Review.
Cited by
-
An Overview of Mucosa-Associated Protozoa: Challenges in Chemotherapy and Future Perspectives.Front Cell Infect Microbiol. 2022 Apr 25;12:860442. doi: 10.3389/fcimb.2022.860442. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35548465 Free PMC article. Review.
-
Giardia and Cryptosporidium antibody prevalence and correlates of exposure among Alaska residents, 2007-2008.Epidemiol Infect. 2018 May;146(7):888-894. doi: 10.1017/S095026881800078X. Epub 2018 Apr 10. Epidemiol Infect. 2018. PMID: 29633686 Free PMC article.
-
Multiple introductions and recombination events underlie the emergence of a hyper-transmissible Cryptosporidium hominis subtype in the USA.Cell Host Microbe. 2023 Jan 11;31(1):112-123.e4. doi: 10.1016/j.chom.2022.11.013. Epub 2022 Dec 14. Cell Host Microbe. 2023. PMID: 36521488 Free PMC article.
-
Molecular typing of Cryptosporidium in Israel.PLoS One. 2019 Sep 3;14(9):e0219977. doi: 10.1371/journal.pone.0219977. eCollection 2019. PLoS One. 2019. PMID: 31479457 Free PMC article.
-
Molecular epidemiologic tools for waterborne pathogens Cryptosporidium spp. and Giardia duodenalis.Food Waterborne Parasitol. 2017 Sep 29;8-9:14-32. doi: 10.1016/j.fawpar.2017.09.002. eCollection 2017 Sep-Dec. Food Waterborne Parasitol. 2017. PMID: 32095639 Free PMC article. Review.
References
-
- Warren C, Guerrant R. Clinical disease and pathology. In: Fayer R, Xiao L, eds. Cryptosporidium and Cryptosporidiosis, 2nd edn. Boca Raton, FL: CDC Press, 2008, pp. 235–254.
-
- U.S. Food and Drug Administration. Alinia (nitazoxanide) label approved 21 July 2004.
-
- U.S. Food and Drug Administration. Alinia (nitazoxanide) label approved 16 June 2005.
-
- Painter JE, et al. Cryptosporidiosis surveillance – United States, 2011–2012. Morbidity and Mortality Weekly Report. Surveillance Summaries 2015; 64: 1–14.